2013/2215(DEC) | [ParlTrack]

View current state | View Changes for this date

Awaiting Parliament 1st reading / single reading / budget 1st stage

2013/2215(DEC) 2012 discharge: European Medicines Agency (EMA)
Next event: Debate in plenary scheduled 2014/04/02 more...

Role	Committee	Rapporteur	Shadows
Lead	CONT	SARVAMAA Petri (EPP)	KADENBACH Karin (S&D), GERBRANDY Gerben-Jan (ALDE), STAES Bart (Verts/ALE), ANDREASEN Marta (ECR), DE JONG Cornelis (GUE/NGL), VANHECKE Frank (EFD), EHRENHAUSER Martin (NI)
Opinion	ENVI	HAUG Jutta (S&D)

Lead committee dossier: CONT/7/13880

Subjects

8.70.03.02 2012 discharge

Links

Activites

2014/04/03 Vote in plenary scheduled
2014/04/02 Debate in plenary scheduled
2014/03/21 Committee report tabled for plenary, single reading
2014/03/17 Vote in committee, 1st reading/single reading
2013/10/22 Committee referral announced in Parliament, 1st reading/single reading
2013/07/26 Non-legislative basic document published
- COM(2013)0570 summary
  
  PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2012, as part of the 2012 discharge procedure. Analysis of the accounts of the European Medicines Agency (EMEA). CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2012 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the European Medicines Agency (EMEA). In 2012, the tasks and budget of this agency were as follows: · description of the Agency's tasks: the European Medicines Agency, which is located in London, was created by Council Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council and its role is the coordination of the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use on the basis of a centralised procedure; · the Agency's budget for the 2012 financial year: the Agency’s budget for 2012, as presented in the Commission document on the consolidated annual accounts of the European Union, gives the following figures: § Commitment appropriations: - committed : EUR 226 million; - paid : EUR 222 million; - carried over : 0. § Payment appropriations: - committed : EUR 262 million; - paid : EUR 215 million; - carried over : EUR 41 million. See also the final accounts of the EMA.
- DG {'url': 'http://ec.europa.eu/dgs/budget/', 'title': 'Budget'}, ŠEMETA Algirdas

Documents

Non-legislative basic document published: COM(2013)0570

Amendments	Dossier
29	2013/2215(DEC) 2013/12/18 ENVI 9 amendments... Amendment 1 # Jutta HAUG Draft opinion Paragraph 1 1. Notes that in 2012 the European Medicines Agency had resources available of EUR 222.489 000 of which EUR 28.966 000 had been EU budget contributions; likes to stress that this amount represents 0.021% of the overall EU budget; is satisfied that 575 of 590 available posts had been occupied and notes that 160 contract agents and seconded national experts were employed by the end of 2012 which are 17 less than in 2011; Amendment 2 # Anna ROSBACH Draft opinion Paragraph 3 3. ~~Recogni~~Stresses the three comments made by the Court of Auditors which focuses on the reliability of the accounts, on the legality and regularity of transactions and on the budget management; recognises the Agency's reply; considers the explanations given by the Agency on the introduction of the SAP accounting system to recognise revenue for all fee application types with more precision as well as the information on the validation of its accounting system for intangible assets as ~~fully~~ sufficient; has to point out that the decision taken by the European Court of Justice on the salary method for 2011 from 19 November 2013 has also consequences for payments with regard to the correction coefficient as well as for the applicable exchange rate from EUR to GBP as the salary adjustment package includes also these two issues; in~~vites~~sists that the Agency, in close cooperation with the Commission, to finds a solution in the interest of the employees and in compliance with the rules; wonders why the Court has not commented on the issue of fees payable to schools in previous years, supports the argumentation of the Agency with regard to the payment of school fees in the absence of a European School; has taken note of the reduced amount carried over to 2013 in comparison with 2010 and 2011; is aware that the carry-over is partly related to the new building project; reminds the Agency however on the annuality principle fir the budget; Amendment 3 # Julie GIRLING Draft opinion Paragraph 3 3. ~~Recogni~~Stresses the three comments made by the Court of Auditors which focuses on the reliability of the accounts, on the legality and regularity of transactions and on the budget management; recognises the Agency's reply; considers the explanations given by the Agency on the introduction of the SAP accounting system to recognise revenue for all fee application types with more precision as well as the information on the validation of its accounting system for intangible assets as ~~fully~~ sufficient; has to point out that the decision taken by the European Court of Justice on the salary method for 2011 from 19 November 2013 has also consequences for payments with regard to the correction coefficient as well as for the applicable exchange rate from EUR to GBP as the salary adjustment package includes also these two issues; in~~vites~~sists that the Agency, in close cooperation with the Commission, to finds a solution in the interest of the employees and in compliance with the rules; wonders why the Court has not commented on the issue of fees payable to schools in previous years, supports the argumentation of the Agency with regard to the payment of school fees in the absence of a European School; has taken note of the reduced amount carried over to 2013 in comparison with 2010 and 2011; is aware that the carry-over is partly related to the new building project; reminds the Agency however on the annuality principle fir the budget; Amendment 4 # Antonyia PARVANOVA Draft opinion Paragraph 3 3. Recognises the three comments made by the Court of Auditors which focuses on the reliability of the accounts, on the legality and regularity of transactions and on the budget management; recognises the Agency's reply; considers the explanations given by the Agency on the introduction of the SAP accounting system to recognise revenue for all fee application types with more precision as well as the information on the validation of its accounting system for intangible assets as fully sufficient; ~~has to~~ points out that the decision taken by the European Court of Justice on the salary method for 2011 from 19 November 2013 has also consequences for payments with regard to the correction coefficient as well as for the applicable exchange rate from EUR to GBP as the salary adjustment package includes also these two issues; invites the Agency, in close cooperation with the Commission, to find a solution in the interest of the employees and in compliance with the rules; wonders why the Court has not commented on the issue of fees payable to schools in previous years, supports the argumentation of the Agency with regard to the payment of school fees in the absence of a European School; has taken note of the reduced amount carried over to 2013 in comparison with 2010 and 2011; is aware that the carry-over is partly related to the new building project; reminds the Agency ~~however~~ on the annuality principle fior the budget; Amendment 5 # Antonyia PARVANOVA Draft opinion Paragraph 4 4. Reiterates the important role of the Agency in protecting and promoting public and animal health by assessing and supervising medicines for human or veterinary use; welcomes the policy on the handling of conflict of interests, last updated and endorsed by the Management Board in March 2012; welcomes the adoption of the Agency draft policy on publication and access to clinical-trial data. Amendment 6 # Anna ROSBACH Draft opinion Paragraph 4 a (new) 4a. Believes that the discharge decision should be based upon OECD guidelines to ensure high quality internationally recognised accounting, audit and financial disclosure standards; invites the European institutions to incorporate and commit to introducing OECD guidelines within a common framework for all European institutions and bodies; Amendment 7 # Julie GIRLING Draft opinion Paragraph 4 a (new) 4a. Believes that the discharge decision should be based upon OECD guidelines to ensure high quality internationally recognised accounting, audit and financial disclosure standards; invites the European institutions to incorporate and commit to introducing OECD guidelines within a common framework for all European institutions and bodies; Amendment 8 # Anna ROSBACH Draft opinion Paragraph 5 5. Recommends~~, on the basis of the facts available,~~ that discharge should not be granted to the Executive Director of the European Medicines Agency in respect of the implementation of the Agency’s budget for the financial year 2012. Amendment 9 # Julie GIRLING Draft opinion Paragraph 5 5. Recommends~~, on the basis of the facts available,~~ that discharge should not be granted to the Executive Director of the European Medicines Agency in respect of the implementation of the Agency’s budget for the financial year 2012. source: PE-526.144 2014/02/25 CONT 20 amendments... Amendment 1 # Petri SARVAMAA Proposal for a decision 1 Paragraph 1 1. Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year ~~2012 / Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year~~ 2012; Amendment 10 # Monica MACOVEI Motion for a resolution Recital A a (new) Aa. whereas according to its financial statements, the overall contribution of the Union to the Agency's budget for 2012 amounted to EUR 31 341 107.18, representing a decrease of 6, 50 % compared to 2011, Amendment 11 # Bart STAES Motion for a resolution Paragraph 4 4. Regrets that the Agency has not yet validated its accounting system in the area of intangible fixed assets, which, given the considerable investment in the development of information and communications technology (ICT), is a crucial part of the whole accounting system; calls on the Agency to inform the discharge authority on progress in this regard ~~within the framework of the 2012 discharge follow-up~~before October 2014; Amendment 12 # Ryszard CZARNECKI, Marta ANDREASEN, Philip BRADBOURN, Andrea ČEŠKOVÁ, Derk Jan EPPINK Motion for a resolution Paragraph 8 8. Notes with concern that in 2012, the Agency issued multiple framework contracts for the provision of services; expresses concern that the procurement procedure presented ~~some~~ irregularities affecting the principle of transparency and demands that the Agency address this issue; Amendment 13 # Monica MACOVEI Motion for a resolution Subheading 6 a (new) Prevention and management of conflicts of interests and transparency Amendment 14 # Rina Ronja KARI Motion for a resolution Subheading 6 a (new) Conflicts of interests Amendment 15 # Monica MACOVEI Motion for a resolution Paragraph 10 a (new) 10a. Welcomes the fact that for the second year in a row, the Agency held a public workshop on conflicts of interests, aimed at defining the right balance between ensuring the impartiality and independence of experts involved in the Agency's work while securing the best possible scientific expertise; Amendment 16 # Rina Ronja KARI Motion for a resolution Paragraph 10 a (new) 10a. Looks forward to the revised version of the Agency's conflicts of interests policy; emphasises that the Agency should continue its work to further strengthen its conflicts of interest policy; Amendment 17 # Monica MACOVEI Motion for a resolution Paragraph 10 b (new) 10b. Acknowledges that the Agency revised its policy on the handling of conflicts of interests by the Scientific Committees' members and experts which is expected for endorsement by the Management Board in March 2014; calls on the Agency to present its revised policy to the discharge authority once adopted; Amendment 18 # Rina Ronja KARI Motion for a resolution Paragraph 10 b (new) 10b. Notes that the Agency works together closely with a variety of patient, healthcare and consumer organisations in order to take their opinions into account; calls on the Agency to request the public disclosure of funding information of any patient, consumer and healthcare organisation and to carry out a conflicts of interests check before the Agency involves them in its work; Amendment 19 # Gerben-Jan GERBRANDY, Chris DAVIES, Jan MULDER Performance Amendment 2 # Karin KADENBACH Proposal for a decision 1 Paragraph 1 1. Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year ~~2012 / Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year~~ 2012; Amendment 20 # Gerben-Jan GERBRANDY, Chris DAVIES, Jan MULDER Motion for a resolution Paragraph 11 a (new) 11a. Requests that the Agency communicate the results and impact its work has on European citizens in an accessible way, mainly through its website; Amendment 3 # Ryszard CZARNECKI, Marta ANDREASEN, Philip BRADBOURN, Andrea ČEŠKOVÁ Proposal for a decision 1 Paragraph 1 1. ~~Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2012 /~~ Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2012; Amendment 4 # Bart STAES Proposal for a decision 1 Paragraph 1 1. ~~Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2012 /~~ Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2012; Amendment 5 # Ryszard CZARNECKI, Marta ANDREASEN, Philip BRADBOURN, Andrea ČEŠKOVÁ, Derk Jan EPPINK Proposal for a decision 2 Paragraph 1 1. ~~Approves the closure of the accounts of the European Medicines Agency for the financial year 2012 /~~ Postpones its decision on the closure of the accounts of the European Medicines Agency for the financial year 2012; Amendment 6 # Petri SARVAMAA Proposal for a decision 2 Paragraph 1 1. Approves the closure of the accounts of the European Medicines Agency for the financial year ~~2012 / Postpones its decision on the closure of the accounts of the European Medicines Agency for the financial year~~ 2012; Amendment 7 # Karin KADENBACH Proposal for a decision 2 Paragraph 1 1. Approves the closure of the accounts of the European Medicines Agency for the financial year ~~2012 / Postpones its decision on the closure of the accounts of the European Medicines Agency for the financial year~~ 2012; Amendment 8 # Elena BĂSESCU Motion for a resolution Citation 10 a (new) – having regard to the previous discharge reports of the Parliament; Amendment 9 # Monica MACOVEI Motion for a resolution Recital A A. whereas, according to its financial statements, the final budget of the European Medicines Agency (‘"the Agency’") for the financial year 2012 was EUR 222 489 000, representing an increase of 6,52 % compared to 2011, source: PE-521.807

Amendments

Dossier

2013/2215(DEC)

2013/12/18 ENVI 9 amendments...

Amendment 1 #

Jutta HAUG

Draft opinion
Paragraph 1

1. Notes that in 2012 the European Medicines Agency had resources available of EUR 222.489 000 of which EUR 28.966 000 had been EU budget contributions; likes to stress that this amount represents 0.021% of the overall EU budget; is satisfied that 575 of 590 available posts had been occupied and notes that 160 contract agents and seconded national experts were employed by the end of 2012 which are 17 less than in 2011;

Amendment 2 #

Anna ROSBACH

Draft opinion
Paragraph 3

3. ~~Recogni~~Stresses the three comments made by the Court of Auditors which focuses on the reliability of the accounts, on the legality and regularity of transactions and on the budget management; recognises the Agency's reply; considers the explanations given by the Agency on the introduction of the SAP accounting system to recognise revenue for all fee application types with more precision as well as the information on the validation of its accounting system for intangible assets as ~~fully~~ sufficient; has to point out that the decision taken by the European Court of Justice on the salary method for 2011 from 19 November 2013 has also consequences for payments with regard to the correction coefficient as well as for the applicable exchange rate from EUR to GBP as the salary adjustment package includes also these two issues; in~~vites~~sists that the Agency, in close cooperation with the Commission, to finds a solution in the interest of the employees and in compliance with the rules; wonders why the Court has not commented on the issue of fees payable to schools in previous years, supports the argumentation of the Agency with regard to the payment of school fees in the absence of a European School; has taken note of the reduced amount carried over to 2013 in comparison with 2010 and 2011; is aware that the carry-over is partly related to the new building project; reminds the Agency however on the annuality principle fir the budget;

Amendment 3 #

Julie GIRLING

Draft opinion
Paragraph 3

Amendment 4 #

Antonyia PARVANOVA

Draft opinion
Paragraph 3

3. Recognises the three comments made by the Court of Auditors which focuses on the reliability of the accounts, on the legality and regularity of transactions and on the budget management; recognises the Agency's reply; considers the explanations given by the Agency on the introduction of the SAP accounting system to recognise revenue for all fee application types with more precision as well as the information on the validation of its accounting system for intangible assets as fully sufficient; ~~has to~~ points out that the decision taken by the European Court of Justice on the salary method for 2011 from 19 November 2013 has also consequences for payments with regard to the correction coefficient as well as for the applicable exchange rate from EUR to GBP as the salary adjustment package includes also these two issues; invites the Agency, in close cooperation with the Commission, to find a solution in the interest of the employees and in compliance with the rules; wonders why the Court has not commented on the issue of fees payable to schools in previous years, supports the argumentation of the Agency with regard to the payment of school fees in the absence of a European School; has taken note of the reduced amount carried over to 2013 in comparison with 2010 and 2011; is aware that the carry-over is partly related to the new building project; reminds the Agency ~~however~~ on the annuality principle fior the budget;

Amendment 5 #

Antonyia PARVANOVA

Draft opinion
Paragraph 4

4. Reiterates the important role of the Agency in protecting and promoting public and animal health by assessing and supervising medicines for human or veterinary use; welcomes the policy on the handling of conflict of interests, last updated and endorsed by the Management Board in March 2012; welcomes the adoption of the Agency draft policy on publication and access to clinical-trial data.

Amendment 6 #

Anna ROSBACH

Draft opinion
Paragraph 4 a (new)

4a. Believes that the discharge decision should be based upon OECD guidelines to ensure high quality internationally recognised accounting, audit and financial disclosure standards; invites the European institutions to incorporate and commit to introducing OECD guidelines within a common framework for all European institutions and bodies;

Amendment 7 #

Julie GIRLING

Draft opinion
Paragraph 4 a (new)

Amendment 8 #

Anna ROSBACH

Draft opinion
Paragraph 5

5. Recommends~~, on the basis of the facts available,~~ that discharge should not be granted to the Executive Director of the European Medicines Agency in respect of the implementation of the Agency’s budget for the financial year 2012.

Amendment 9 #

Julie GIRLING

Draft opinion
Paragraph 5

source: PE-526.144

2014/02/25 CONT 20 amendments...

Amendment 1 #

Petri SARVAMAA

Proposal for a decision 1
Paragraph 1

1. Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year ~~2012 / Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year~~ 2012;

Amendment 10 #

Monica MACOVEI

Motion for a resolution
Recital A a (new)

Aa. whereas according to its financial statements, the overall contribution of the Union to the Agency's budget for 2012 amounted to EUR 31 341 107.18, representing a decrease of 6, 50 % compared to 2011,

Amendment 11 #

Bart STAES

Motion for a resolution
Paragraph 4

4. Regrets that the Agency has not yet validated its accounting system in the area of intangible fixed assets, which, given the considerable investment in the development of information and communications technology (ICT), is a crucial part of the whole accounting system; calls on the Agency to inform the discharge authority on progress in this regard ~~within the framework of the 2012 discharge follow-up~~before October 2014;

Amendment 12 #

Ryszard CZARNECKI, Marta ANDREASEN, Philip BRADBOURN, Andrea ČEŠKOVÁ, Derk Jan EPPINK

Motion for a resolution
Paragraph 8

8. Notes with concern that in 2012, the Agency issued multiple framework contracts for the provision of services; expresses concern that the procurement procedure presented ~~some~~ irregularities affecting the principle of transparency and demands that the Agency address this issue;

Amendment 13 #

Monica MACOVEI

Motion for a resolution
Subheading 6 a (new)

Prevention and management of conflicts of interests and transparency

Amendment 14 #

Rina Ronja KARI

Motion for a resolution
Subheading 6 a (new)

Conflicts of interests

Amendment 15 #

Monica MACOVEI

Motion for a resolution
Paragraph 10 a (new)

10a. Welcomes the fact that for the second year in a row, the Agency held a public workshop on conflicts of interests, aimed at defining the right balance between ensuring the impartiality and independence of experts involved in the Agency's work while securing the best possible scientific expertise;

Amendment 16 #

Rina Ronja KARI

Motion for a resolution
Paragraph 10 a (new)

10a. Looks forward to the revised version of the Agency's conflicts of interests policy; emphasises that the Agency should continue its work to further strengthen its conflicts of interest policy;

Amendment 17 #

Monica MACOVEI

Motion for a resolution
Paragraph 10 b (new)

10b. Acknowledges that the Agency revised its policy on the handling of conflicts of interests by the Scientific Committees' members and experts which is expected for endorsement by the Management Board in March 2014; calls on the Agency to present its revised policy to the discharge authority once adopted;

Amendment 18 #

Rina Ronja KARI

Motion for a resolution
Paragraph 10 b (new)

10b. Notes that the Agency works together closely with a variety of patient, healthcare and consumer organisations in order to take their opinions into account; calls on the Agency to request the public disclosure of funding information of any patient, consumer and healthcare organisation and to carry out a conflicts of interests check before the Agency involves them in its work;

Amendment 19 #

Gerben-Jan GERBRANDY, Chris DAVIES, Jan MULDER

Performance

Amendment 2 #

Karin KADENBACH

Proposal for a decision 1
Paragraph 1

Amendment 20 #

Gerben-Jan GERBRANDY, Chris DAVIES, Jan MULDER

Motion for a resolution
Paragraph 11 a (new)

11a. Requests that the Agency communicate the results and impact its work has on European citizens in an accessible way, mainly through its website;

Amendment 3 #

Ryszard CZARNECKI, Marta ANDREASEN, Philip BRADBOURN, Andrea ČEŠKOVÁ

Proposal for a decision 1
Paragraph 1

1. ~~Grants the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2012 /~~ Postpones its decision on granting the Executive Director of the European Medicines Agency discharge in respect of the implementation of the Agency's budget for the financial year 2012;

Amendment 4 #

Bart STAES

Proposal for a decision 1
Paragraph 1

Amendment 5 #

Ryszard CZARNECKI, Marta ANDREASEN, Philip BRADBOURN, Andrea ČEŠKOVÁ, Derk Jan EPPINK

Proposal for a decision 2
Paragraph 1

1. ~~Approves the closure of the accounts of the European Medicines Agency for the financial year 2012 /~~ Postpones its decision on the closure of the accounts of the European Medicines Agency for the financial year 2012;

Amendment 6 #

Petri SARVAMAA

Proposal for a decision 2
Paragraph 1

1. Approves the closure of the accounts of the European Medicines Agency for the financial year ~~2012 / Postpones its decision on the closure of the accounts of the European Medicines Agency for the financial year~~ 2012;

Amendment 7 #

Karin KADENBACH

Proposal for a decision 2
Paragraph 1

Amendment 8 #

Elena BĂSESCU

Motion for a resolution
Citation 10 a (new)

– having regard to the previous discharge reports of the Parliament;

Amendment 9 #

Monica MACOVEI

Motion for a resolution
Recital A

A. whereas, according to its financial statements, the final budget of the European Medicines Agency (‘"the Agency’") for the financial year 2012 was EUR 222 489 000, representing an increase of 6,52 % compared to 2011,

source: PE-521.807

History

(these mark the time of scraping, not the official date of the change)

2014-03-25Show (3) Changes | Timetravel

activities/0/docs/0/celexid	Old CELEX:52013DC0570:EN New CELEX:52013PC0570:EN
activities/0/docs/0/url	Old http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=570 New http://old.eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=570
activities/3/docs	url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2014-0227&language=EN type: Committee report tabled for plenary, single reading title: A7-0227/2014

2014-03-22Show (2) Changes | Timetravel

activities/3	date 2014-03-21T00:00:00 body EP type Committee report tabled for plenary, single reading
procedure/stage_reached	Old Awaiting committee decision New Awaiting Parliament 1st reading / single reading / budget 1st stage

2014-03-20Show (1) Changes | Timetravel

activities/2

date: 2014-03-17T00:00:00

body: EP

type: Vote in committee, 1st reading/single reading

committees: body: EP shadows: group: S&D name: KADENBACH Karin group: ALDE name: GERBRANDY Gerben-Jan group: Verts/ALE name: STAES Bart group: ECR name: ANDREASEN Marta group: GUE/NGL name: DE JONG Cornelis group: EFD name: VANHECKE Frank group: NI name: EHRENHAUSER Martin responsible: True committee: CONT date: 2013-10-10T00:00:00 committee_full: Budgetary Control rapporteur: group: EPP name: SARVAMAA Petri body: EP responsible: False committee: ENVI date: 2013-10-10T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: S&D name: HAUG Jutta

2014-03-18Show (2) Changes | Timetravel

activities/2/type	Old Indicative plenary sitting date, 1st reading/single reading New Debate in plenary scheduled
activities/3	date 2014-04-03T00:00:00 body EP type Vote in plenary scheduled

2014-02-14Show (1) Changes | Timetravel

activities/0/docs/0/celexid

Old

CELEX:52013PC0570:EN

New

CELEX:52013DC0570:EN

2014-02-13Show (1) Changes | Timetravel

activities/0/docs/0/celexid

Old

CELEX:52013DC0570:EN

New

CELEX:52013PC0570:EN

2014-01-18Show (1) Changes | Timetravel

activities/0/type

Old

Non-legislative basic document

New

Non-legislative basic document published

2013-12-17Show (3) Changes | Timetravel

activities/1	date 2013-10-22T00:00:00 body EP type Committee referral announced in Parliament, 1st reading/single reading committees body: EP shadows: group: S&D name: KADENBACH Karin group: ALDE name: GERBRANDY Gerben-Jan group: Verts/ALE name: STAES Bart group: ECR name: ANDREASEN Marta group: GUE/NGL name: DE JONG Cornelis group: EFD name: VANHECKE Frank group: NI name: EHRENHAUSER Martin responsible: True committee: CONT date: 2013-10-10T00:00:00 committee_full: Budgetary Control rapporteur: group: EPP name: SARVAMAA Petri body: EP responsible: False committee: ENVI date: 2013-10-10T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: S&D name: HAUG Jutta
procedure/dossier_of_the_committee	CONT/7/13880
procedure/stage_reached	Old Preparatory phase in Parliament New Awaiting committee decision

2013-12-16Show (1) Changes | Timetravel

activities/0/docs/0/celexid

Old

CELEX:52013PC0570:EN

New

CELEX:52013DC0570:EN

2013-12-15Show (1) Changes | Timetravel

activities/0/docs/0/celexid

Old

CELEX:52013DC0570:EN

New

CELEX:52013PC0570:EN

2013-12-08Show (1) Changes | Timetravel

activities/0/docs/0/celexid

CELEX:52013DC0570:EN

2013-12-06Show (2) Changes | Timetravel

activities/0/docs/0/celexid	CELEX:52013DC0570:EN
committees/0/shadows/3	group ECR name ANDREASEN Marta

2013-11-24Show (1) Changes | Timetravel

activities/0/docs/0/text

PURPOSE: presentation by the Commission of the consolidated annual accounts of the European Union for the financial year 2012, as part of the 2012 discharge procedure.

Analysis of the accounts of the European Medicines Agency (EMEA).

CONTENT: this Commission document sets out the consolidated annual accounts of the European Union for the financial year 2012 as prepared on the basis of the information presented by the institutions, organisations and bodies of the EU, in accordance with Article 129 (2) of the Financial Regulation applicable to the EU's General Budget, including the European Medicines Agency (EMEA).

In 2012, the tasks and budget of this agency were as follows:

·        description of the Agency's tasks: the European Medicines Agency, which is located in London, was created by Council Regulation (EEC) No 2309/93, which was replaced by Regulation (EC) No 726/2004 of the European Parliament and of the Council and its role is the coordination of the scientific resources made available by the national authorities in order to ensure the evaluation and supervision of medicinal products for human or veterinary use on the basis of a centralised procedure;

·        the Agency's budget for the 2012 financial year: the Agency’s budget for 2012, as presented in the Commission document on the consolidated annual accounts of the European Union, gives the following figures:

§         Commitment appropriations:

- committed : EUR 226 million;

- paid : EUR 222 million;

- carried over : 0.

§         Payment appropriations:

- committed : EUR 262 million;

- paid : EUR 215 million;

- carried over : EUR 41 million.

See also the final accounts of the EMA.

2013-11-06Show (1) Changes | Timetravel

activities/0/docs/0/url

http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=570

2013-11-05Show (5) Changes

activities	date: 2013-07-26T00:00:00 docs: celexid: CELEX:52013DC0570:EN type: Non-legislative basic document published title: COM(2013)0570 body: EC type: Non-legislative basic document commission: DG: url: http://ec.europa.eu/dgs/budget/ title: Budget Commissioner: ŠEMETA Algirdas date: 2014-04-02T00:00:00 body: EP type: Indicative plenary sitting date, 1st reading/single reading
committees	body: EP shadows: group: S&D name: KADENBACH Karin group: ALDE name: GERBRANDY Gerben-Jan group: Verts/ALE name: STAES Bart group: GUE/NGL name: DE JONG Cornelis group: EFD name: VANHECKE Frank group: NI name: EHRENHAUSER Martin responsible: True committee: CONT date: 2013-10-10T00:00:00 committee_full: Budgetary Control rapporteur: group: EPP name: SARVAMAA Petri body: EP responsible: False committee: ENVI date: 2013-10-10T00:00:00 committee_full: Environment, Public Health and Food Safety rapporteur: group: S&D name: HAUG Jutta
links
other	body: EC dg: url: http://ec.europa.eu/dgs/budget/ title: Budget commissioner: ŠEMETA Algirdas
procedure	stage_reached Preparatory phase in Parliament subject 8.70.03.02 2012 discharge type DEC - Discharge procedure reference 2013/2215(DEC) title 2012 discharge: European Medicines Agency (EMA)

Activites

Documents

History

ParlTrack - 2011-2024